Topics

Sanofi wins FDA approval to sell dengue shot in parts of U.S.

20:13 EDT 1 May 2019 | Reuters

The U.S. Food and Drug Administration on Wednesday approved Sanofi SA's dengue vaccine Dengvaxia for use in the United States among people aged 9 through 16 who have laboratory-confirmed previous dengue infection and live in endemic areas. (https://b...

Original Article: Sanofi wins FDA approval to sell dengue shot in parts of U.S.

NEXT ARTICLE

More From BioPortfolio on "Sanofi wins FDA approval to sell dengue shot in parts of U.S."

Quick Search

Relevant Topics

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

Infectious-diseases
Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...